WuXi XDC Cayman company profile

Company profile

WuXi XDC Cayman has 3,628 employees and is headquartered in Wuxi, China.

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. Additionally, the company engages in the research and development, manufacturing, and marketing of anti-tumor drugs. WuXi XDC Cayman Inc. has a strategic collaboration with Earendil Labs; and Akari Therapeutics. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.

Company facts

Sector

Industrials

Industry

Diagnostics & Research

Country

Hong Kong SAR China

Headquarters

No. 11 Xinhui Ring Road, Wuxi

Employees

3,628

Listing

2268 · HKEX

Currency

HKD

Website

wuxixdc.com